259
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Is gentamicin necessary in the antimicrobial treatment for group B streptococcal infections in the elderly? An in vitro study with human blood products

, &
Pages 185-192 | Received 19 Jun 2016, Accepted 26 Sep 2016, Published online: 21 Oct 2016

References

  • Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA. 2008;299:2056–2065.
  • Skoff TH, Farley MM, Petit S, et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990–2007. Clin Infect Dis. 2009;49:85–92.
  • Polin RA. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129:1006–1015.
  • Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645–1654.
  • Westling K, Aufwerber E, Ekdahl C, et al. Swedish guidelines for diagnosis and treatment of infective endocarditis. Scand J Infect Dis. 2007;39:929–946.
  • Baker CN, Thornsberry C, Facklam RR. Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci. Antimicrob Agents Chemother. 1981;19:716–725.
  • Cooper MD, Keeney RE, Lyons SF, et al. Synergistic effects of ampicillin-aminoglycoside combinations on group B Streptococci. Antimicrob Agents Chemother. 1979;15:484–486.
  • Swingle HM, Bucciarelli RL, Ayoub EM. Synergy between penicillins and low concentrations of gentamicin in the killing of group B Streptococci. J Infect Dis. 1985;152:515–520.
  • Pillai SK, Moellering RC, Jr, Eliopoulos GM. Antimicrobial combinations. In: Lorian V, editor. Antibiotics in laboratory medicine. Philadelphia (PA): Lippincott Williams & Wilkins; 2005. p. 365–440.
  • Gonzalez LS, 3rd, Spencer JP. Aminoglycosides: a practical review. Am Fam Phys. 1998;58:1811–1820.
  • Ballard MS, Schønheyder HC, Knudsen JD, et al. The changing epidemiology of group B streptococcus bloodstream infection: a multi-national population-based assessment. Infect Dis (Lond). 2016;48:386–391.
  • Hilmer SN, Tran K, Rubie P, et al. Gentamicin pharmacokinetics in old age and frailty. Br J Clin Pharmacol. 2011;71:224–231.
  • Schroder AK, Rink L. Neutrophil immunity of the elderly. Mech Ageing Dev. 2003;124:419–425.
  • Ginaldi L, De Martinis M, D'Ostilio A, et al. Immunological changes in the elderly. Aging (Milano). 1999;11:281–286.
  • Butcher S, Chahel H, Lord JM. Review article: ageing and the neutrophil: no appetite for killing? Immunology. 2000;100:411–416.
  • Ruppen C, Lupo A, Decosterd L, et al. Is penicillin plus gentamicin synergistic against clinical group B Streptococcus isolates? An in-vitro study. Front Microbiol. 2016;7. doi:10.3389/fmicb.2016.01680.
  • Sendi P, Furitsch M, Mauerer S, et al. Chromosomally and extrachromosomally mediated high-level gentamicin resistance in Streptococcus agalactiae. Antimicrob Agents Chemother. 2016;60:1702–1707.
  • Rolinson GN, Sutherland R. The binding of antibiotics to serum proteins. Br J Pharmacol Chemother. 1965;25:638–650.
  • Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369–2413.
  • Dwyer M, Gadjeva M. Opsonophagocytic assay. Methods Mol Biol. 2014;1100:373–379.
  • Sendi P, Johansson L, Dahesh S, et al. Bacterial phenotype variants in group B streptococcal toxic shock syndrome. Emerg Infect Dis. 2009;15:223–232.
  • Nahm MH, Burton RL. Protocol for opsonophagocytic killing assay for antibodies against group B Streptococcus (UAB GBS OPA). Bacterial Respiratory Pathogen Reference Laboratory [Internet]; 2013; [cited 2015 Aug 10]. Protocols and software. 24 pp. Available from: http://www.vaccine.uab.edu/UAB-MOPA.pdf.
  • Sagar A, Klemm C, Hartjes L, et al. The β-hemolysin and intracellular survival of Streptococcus agalactiae in human macrophages. PLoS One. 2013;8:e60160.
  • Geering B, Stoeckle C, Rozman S, et al. DAPK2 positively regulates motility of neutrophils and eosinophils in response to intermediary chemoattractants. J Leukoc Biol. 2014;95:293–303.
  • Tak T, Tesselaar K, Pillay J, et al. What's your age again? Determination of human neutrophil half-lives revisited. J Leukoc Biol. 2013;94:595–601.
  • Liu GY, Doran KS, Lawrence T, et al. Sword and shield: Linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proc Natl Acad Sci USA. 2004;101:14491–14496.
  • Ruppen C, Sendi P. Time kill assays for Streptococcus agalactiae and synergy testing. Nature Protocol Exchange [Internet]; 2015 [cited 2015 Dec 28]. Protocols. Available from: http://www.nature.com/protocolexchange/protocols/4505.
  • Garcia LS, editor. Clinical microbiology procedures handbook. 3rd ed. Vol. 2. Washington (DC): ASM Press; 2010. Moody J, Knapp C. Tests to assess bactericidal activity. p. 5.10.1.1–5.10.3.6.
  • Sutton S. Accuracy of plate counts. J Validat Technol. 2011;17:42–46.
  • Baron Barshak M, Madoff LC. Group B streptococcal infections in nonpregnant adults. UpToDate Wolters Kluwer Health [Internet]; 2016 [cited 2016 Sep 21]. Available from: http://www.uptodate.com/contents/group-b-streptococcal-infections-in-nonpregnant-adults?source=search_result&search=gbs&selectedTitle =6%7E107.
  • Puttaswamy S, Lee BD, Sengupta S. Novel electrical method for early detection of viable bacteria in blood cultures. J Clin Microbiol. 2011;49:2286–2289.
  • Yagupsky P, Nolte FS. Quantitative aspects of septicemia. Clin Microbiol Rev. 1990;3:269–279.
  • Geddes AM, Gould IM. Benzylpenicillin (Penicillin G). In: Grayson ML, editor. Kucers' the use of antibiotics. Sixth edition: a clinical review of antibacterial, antifungal and antiviral drugs. London, UK: Hodder Arnold; 2010. p. 5–58.
  • Li Y, Karlin A, Loike JD, et al. A critical concentration of neutrophils is required for effective bacterial killing in suspension. Proc Natl Acad Sci USA. 2002;99:8289–8294.
  • Brook I. Inoculum effect. Rev Infect Dis. 1989;11:361–368.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.